Pharming CEO Chouraqui steps down; names Marsh, Lynard interim co-CEOs
PHAR•Pharming said Fabrice Chouraqui stepped down as CEO and executive director with immediate effect, naming Leverne Marsh and Kenneth Lynard interim co-CEOs while it searches for a permanent successor.
1. Interim leadership appointed
Pharming named Chief Commercial Officer Leverne Marsh interim co-CEO to run patient-focused operations and Chief Financial Officer Kenneth Lynard interim co-CEO to oversee global corporate functions. The board launched a formal search for a permanent CEO successor.
